On World Health Issues, Let Them Eat Cake
Where is the surprise, I ponder. Essentially the flow of “aid” or assistance from rich countries is in two parts of government money: channeled through charities and NGOs or partial subsidies of the pharmaceutical companies, or through direct research and development money from private companies.
Cures for known diseases are not a big money-maker for the pharmaceutical companies. Medications and preventative materials are old, tested goods and “generic” merchandise. Patents and other intellectual property rights have long expired for medications for malaria and the like, and thus from a business point of view, those products are either generic or very low profit. Moreover, planners sit in air-conditioned offices of modern cities, sip bottled water and pay the weekly wage of an African patient for a triple cappuccino and a piece of bread. Their daily dilemma is to choose between two different luxuries to pacify their boredom. Worries about basic needs such as clean water, sanitation or inoculation for locally “eradicated” diseases is a remote concern in, say, Copenhagen or Atlanta. Thus the focus is on fame and fortune--if a miracle drug is found for HIV/AIDS, heart attack, cancer or other diseases, there is a large, rich customer base in high-stress, urban living areas.

